Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy and Tolerance of TOPIALYSE Baume Protect+ Vs Neutral Product on Patients Suffering from Atopic Dermatitis

NCT06108570 is registered in ClinicalTrials.gov with SVR Group as lead sponsor.

NCT NCT06108570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06108570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy and Tolerance of TOPIALYSE Baume Protect+ Vs Neutral Product on Patients Suffering from Atopic Dermatitis
Lead sponsor
SVR Group
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2023
Completion date
August 22, 2024
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis